Nomura Micro Science Co., Ltd. (6254) AI Stock Analysis

• Market Cap: ¥151.32B
• Dividend Yield: 2.03%
• Average Volume (3M): 755.66K
• Price to Earnings (P/E): 14.1
• Beta (1Y): 1.46
• Revenue Growth: 48.98%
• EPS Growth: 39.43%
• Country: JP
• Employees: 545
• Sector: Industrials
• Sector Strength: 72
• Industry: Industrial - Machinery
• EPS (TTM): 12.27
• Shares Outstanding: 40,608,000
• 10 Day Avg. Volume: 795,700
• 30 Day Avg. Volume: 755,656
• PEG Ratio: 0.33
• Price to Book (P/B): 2.45
• Price to Sales (P/S): 0.94
• P/FCF Ratio: -4.06
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 76 Outperform
• Price Target: ¥4,189.00 ▲(7.69% Upside)

Nomura Micro Science Co., Ltd. scores well due to its strong financial performance and positive technical indicators. The stock is reasonably valued with a solid dividend yield, making it attractive for both growth and income investors. However, the need for improved cash flow management is a key area for future focus.

Nomura Micro Science Co., Ltd. Business Overview & Revenue Model

Company Description

Nomura Micro Science Co., Ltd. (6254) is a Japanese company specializing in the development and manufacturing of advanced micro-precision components and systems used in various sectors, including electronics, telecommunications, and medical devices. The company focuses on leveraging its expertise in microfabrication and precision engineering to deliver high-quality products such as micro motors, sensors, and other specialized micro-components that cater to the growing demand for miniaturization in technology.

How the Company Makes Money

Nomura Micro Science generates revenue primarily through the sale of its micro-precision components and systems to a diverse range of industries. Key revenue streams include direct sales to manufacturers in the electronics and telecommunications sectors, as well as partnerships with medical device companies for custom micro-engineered solutions. The company also engages in research and development collaborations, which may lead to additional funding and revenue opportunities through grants or joint ventures. Significant partnerships with leading technology firms enhance its market presence and contribute to its earnings by providing access to new markets and customers.

Nomura Micro Science Co., Ltd. Financial Statement Overview

Summary

Nomura Micro Science Co., Ltd. demonstrates robust financial performance with strong revenue and profit growth. The balance sheet reflects financial stability, but the company must focus on improving cash flow generation to support long-term objectives. Overall, the financial health is sound, with opportunities to enhance cash management.

Income Statement

Nomura Micro Science Co., Ltd. has exhibited strong revenue growth, with a notable increase in total revenue from 2024 to 2025. Gross profit and net profit margins have improved, indicating enhanced operational efficiency and profitability. The EBIT and EBITDA margins are solid, reflecting effective cost management and a healthy earnings profile.

Balance Sheet

The company's balance sheet shows a moderate debt-to-equity ratio, suggesting a balanced approach to leveraging. The return on equity is strong, driven by rising net income and shareholder equity. The equity ratio indicates a stable financial structure, though the increase in total debt in recent years warrants attention.

Cash Flow

The cash flow analysis reveals challenges, with negative free cash flow and operating cash flow over the recent periods. However, there is a significant improvement in free cash flow from 2024 to 2025. The company needs to address cash flow generation to ensure sustainable growth.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	101.13B	96.36B	73.02B	49.60B	31.90B	30.36B
Gross Profit	22.16B	21.11B	15.41B	10.37B	7.66B	7.13B
EBITDA	17.90B	16.95B	11.72B	7.70B	4.78B	3.77B
Net Income	10.25B	10.20B	7.98B	5.81B	3.29B	2.62B
Balance Sheet
Total Assets	103.87B	116.78B	70.60B	41.92B	27.09B	24.76B
Cash, Cash Equivalents and Short-Term Investments	18.89B	17.33B	12.14B	14.12B	10.08B	9.86B
Total Debt	47.98B	53.20B	22.40B	3.47B	2.69B	2.63B
Total Liabilities	68.92B	79.77B	41.68B	20.52B	11.16B	11.57B
Stockholders Equity	34.95B	37.01B	28.92B	21.40B	15.93B	13.19B
Cash Flow
Free Cash Flow	0.00	-22.31B	-19.02B	3.65B	771.34M	5.80B
Operating Cash Flow	0.00	-18.73B	-18.66B	4.68B	1.13B	5.96B
Investing Cash Flow	0.00	-2.74B	386.99M	64.81M	134.01M	-433.48M
Financing Cash Flow	0.00	27.18B	17.45B	-24.90M	-881.82M	-937.84M

Nomura Micro Science Co., Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 3890.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:6254, the sentiment is Positive. The current price of 3890 is above the 20-day moving average (MA) of 3589.50, above the 50-day MA of 3357.98, and above the 200-day MA of 2668.76, indicating a bullish trend. The MACD of 157.92 indicates Negative momentum. The RSI at 65.31 is Neutral, neither overbought nor oversold. The STOCH value of 87.10 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:6254.

Nomura Micro Science Co., Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
6254	―	¥151.32B	14.08	―	2.03%	48.98%	39.43%
6490	―	¥114.08B	13.53	―	2.51%	-0.98%	-18.48%
6284	―	¥98.19B	13.06	―	2.92%	15.99%	32.43%
6340	―	¥94.90B	9.36	―	2.64%	11.77%	2.77%
6482	―	¥19.81B	11.92	―	3.10%	5.39%	-0.34%
6486	―	¥134.55B	23.64	―	3.90%	>-0.01%	-26.82%
Sector *	―	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%

Nomura Micro Science Co., Ltd. Corporate Events

Nomura Micro Science Issues Stock Options to Boost Performance

Nomura Micro Science Co., Ltd. announced the issuance of stock options to its executive officers and employees to align business performance with stock value and enhance motivation for long-term corporate value improvement. This move is expected to strengthen the company’s operational performance and market position by incentivizing key personnel to contribute to its growth.

Nomura Micro Science Reports Strong Financial Growth in Q1 2025

Nomura Micro Science Co., Ltd. reported a significant increase in its consolidated financial results for the three months ending June 30, 2025, with net sales rising by 62.6% year-on-year. The company also saw substantial growth in operating profit and ordinary profit, indicating a strong recovery and positive momentum in its business operations.